DK0918507T4 - Aerosolformuleringer - Google Patents
Aerosolformuleringer Download PDFInfo
- Publication number
- DK0918507T4 DK0918507T4 DK97925141.0T DK97925141T DK0918507T4 DK 0918507 T4 DK0918507 T4 DK 0918507T4 DK 97925141 T DK97925141 T DK 97925141T DK 0918507 T4 DK0918507 T4 DK 0918507T4
- Authority
- DK
- Denmark
- Prior art keywords
- medicament
- propellant
- product
- solvent
- formulation
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
- B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/44—Valves specially adapted therefor; Regulating devices
- B65D83/52—Valves specially adapted therefor; Regulating devices for metering
- B65D83/54—Metering valves ; Metering valve assemblies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Mechanical Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9616237.5A GB9616237D0 (en) | 1996-08-01 | 1996-08-01 | Aerosol formulations |
PCT/GB1997/001502 WO1998005302A1 (en) | 1996-08-01 | 1997-06-03 | Aerosol formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0918507T3 DK0918507T3 (da) | 2002-07-29 |
DK0918507T4 true DK0918507T4 (da) | 2016-03-14 |
Family
ID=10797901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97925141.0T DK0918507T4 (da) | 1996-08-01 | 1997-06-03 | Aerosolformuleringer |
Country Status (14)
Country | Link |
---|---|
US (3) | US7566445B1 (da) |
EP (1) | EP0918507B2 (da) |
JP (2) | JP4794701B2 (da) |
AT (1) | ATE215359T2 (da) |
AU (1) | AU721920B2 (da) |
CA (1) | CA2261879C (da) |
DE (1) | DE69711637T3 (da) |
DK (1) | DK0918507T4 (da) |
ES (1) | ES2175413T5 (da) |
GB (1) | GB9616237D0 (da) |
NO (1) | NO325491B1 (da) |
NZ (1) | NZ333986A (da) |
PT (1) | PT918507E (da) |
WO (1) | WO1998005302A1 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
US5874481A (en) * | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
CZ20011362A3 (cs) * | 1998-10-17 | 2001-09-12 | Boehringer Ingelheim Pharma Kg | Skladovatelný koncentrát účinné látky s formoterolem |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
JP5392880B2 (ja) | 2000-05-22 | 2014-01-22 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
TR200401980T4 (tr) | 2001-07-02 | 2004-09-21 | Chiesi Farmaceutici S.P.A. | Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu |
SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
WO2007068007A1 (en) * | 2005-12-07 | 2007-06-14 | Harm Benjamin Steyn | Use of a disinfectant for treating respiratory tract infections |
GB0712454D0 (en) | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
BR112012007182A8 (pt) * | 2009-09-29 | 2017-12-26 | Mary Trill Helen | Uso de um material arrastado em dessecante, válvula de dosagem de inalador pressurizado de dose medida, sistema de recipiente fechado de inalador pressurizado de dose medida, e, método para estabilizar a massa de partícula fina (mpf) de uma formulação de droga de inalação |
EP3554127B1 (en) | 2010-11-10 | 2020-09-09 | Panasonic Intellectual Property Corporation of America | Terminal and coding mode selection method |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
US20170189329A1 (en) | 2014-07-29 | 2017-07-06 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
EA201790832A1 (ru) | 2014-10-16 | 2017-09-29 | Тева Брэндид Фармасьютикал Продактс Ар Энд Ди, Инк. | Ингалируемый состав |
US10563361B2 (en) | 2016-01-12 | 2020-02-18 | Ch3 Solutions, Llc | System and method for customizing a playing field |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US261539A (en) * | 1882-07-25 | Sap-pail cover and holder | ||
BE555319A (da) * | 1956-03-21 | 1900-01-01 | ||
BE556587A (da) | 1957-01-31 | 1957-04-11 | ||
AT215359B (de) | 1958-04-05 | 1961-05-25 | Fleissner Gmbh | Siebtrommeltrockner für Fasermaterial |
GB8501015D0 (en) | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
EP0223831B1 (en) | 1985-05-22 | 1992-07-15 | Liposome Technology, Inc. | Liposome inhalation method and system |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5776434A (en) | 1988-12-06 | 1998-07-07 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8921222D0 (en) * | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
US5118494A (en) * | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
EP0526481B1 (en) | 1990-03-23 | 1995-04-26 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
EP0536204B1 (en) | 1990-06-27 | 1994-04-06 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
WO1992000107A1 (en) | 1990-06-28 | 1992-01-09 | Glaxo Inc. | Aerosol drug formulations |
HUT63554A (en) | 1990-06-29 | 1993-09-28 | Fisons Plc | Aerosol preparations under pressure |
WO1992002287A1 (en) | 1990-08-09 | 1992-02-20 | Stokes, Jack, A. | Oil reclaiming device |
US5115803A (en) * | 1990-08-31 | 1992-05-26 | Minnesota Mining And Manufacturing Company | Aerosol actuator providing increased respirable fraction |
ES2064160T3 (es) * | 1990-10-18 | 1995-01-16 | Minnesota Mining & Mfg | Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona. |
GB9024365D0 (en) | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
ES2158910T3 (es) | 1991-06-10 | 2001-09-16 | Schering Corp | Formulaciones en aerosol sin clorofluorocarbonos. |
EP0587790B2 (en) | 1991-06-10 | 2000-03-08 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
AU2178392A (en) | 1991-06-12 | 1993-01-12 | Minnesota Mining And Manufacturing Company | Albuterol sulfate suspension aerosol formulations |
NZ244439A (en) | 1991-09-25 | 1994-01-26 | Fisons Plc | Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed |
DE4132176C2 (de) | 1991-09-27 | 1997-03-13 | Ig Spruehtechnik Gmbh | Dosieraerosole mit Isobutan als Treibmittel |
CA2381329C (en) | 1991-12-12 | 2003-04-15 | Glaxo Group Limited | Medicaments |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
EP0616525B1 (en) * | 1991-12-12 | 1995-09-27 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
DE69233319T2 (de) | 1991-12-18 | 2005-02-17 | Minnesota Mining & Manufacturing Company, St. Paul | Aerosolzusammensetzungen für Arzneimittelsuspensionen |
US5355872B1 (en) * | 1992-03-04 | 1998-10-20 | John H Riggs | Low flow rate nebulizer apparatus and method of nebulization |
US5376359A (en) | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
MX9304585A (es) * | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
RU2126248C1 (ru) * | 1992-12-09 | 1999-02-20 | Берингер Ингельхейм Фармасьютикалз, Инк. | Жидкая фармацевтическая композиция в форме аэрозоля |
US5899201A (en) * | 1993-05-26 | 1999-05-04 | Minnesota Mining And Manufacturing Company | Aerosol actuator |
JPH0780069A (ja) | 1993-09-13 | 1995-03-28 | Otsuka Pharmaceut Co Ltd | プロカテロールを含有するエアゾール製剤 |
EP0735884B1 (en) * | 1993-12-20 | 2000-04-26 | Minnesota Mining And Manufacturing Company | Flunisolide aerosol formulations |
US5635159A (en) | 1994-08-26 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing polyglycolyzed glycerides |
GB9425160D0 (en) | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
PL320856A1 (en) | 1994-12-22 | 1997-11-10 | Astra Ab | Aerosol drug preparations |
US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
HUP9800641A3 (en) | 1995-04-14 | 2001-04-28 | Glaxo Wellcome Inc Res Triangl | Metered dose inhaler for beclomethasone dipropionate |
GB9610341D0 (en) | 1996-05-17 | 1996-07-24 | Andaris Ltd | Formulation for inhalation |
GB9612297D0 (en) | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
GB9616237D0 (en) * | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
KR20000069275A (ko) | 1996-12-04 | 2000-11-25 | 새들러 테리 아이언 | 약학 조성물과 그 투여를 위한 장치 |
CA2280099C (en) | 1997-02-05 | 2005-12-27 | Jago Pharma Ag | Medical aerosol formulations |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US5891419A (en) * | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe flunisolide aerosol formulations for oral inhalation |
GB2326334A (en) | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
GB2332372B (en) | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
ES2141049B1 (es) | 1998-03-11 | 2000-10-16 | Aldo Union S A Lab | Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes. |
PL343491A1 (en) | 1998-04-18 | 2001-08-27 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
EP1087750B1 (en) | 1998-06-18 | 2003-11-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
ES2234266T3 (es) | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
DE59904648D1 (de) | 1998-08-04 | 2003-04-24 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
US6136294C1 (en) | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
US6458338B1 (en) | 1998-09-22 | 2002-10-01 | Aeropharm Technology Incorporated | Amino acid stabilized medicinal aerosol formulations |
US6261539B1 (en) | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
PT1150661E (pt) | 1999-02-05 | 2004-02-27 | Cipla Ltd | Produto para pulverizacao para aplicacao topica |
GB9903759D0 (en) | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
SE9900833D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
DE19924098A1 (de) | 1999-05-26 | 2000-12-07 | Boehringer Ingelheim Pharma | Edelstahlkanister für treibgasbetriebene Dosieraerosole |
CN1144582C (zh) | 2000-11-28 | 2004-04-07 | 中国药科大学 | 治疗呼吸系统疾病的无氟里昂药用气雾剂 |
WO2003072777A1 (fr) | 2002-02-27 | 2003-09-04 | Yasumitsu Nagao | Animal dont l'embryon est modifie et procede de construction de cet animal |
JP4527949B2 (ja) | 2003-06-24 | 2010-08-18 | ニプロパッチ株式会社 | 粘着テープ |
-
1996
- 1996-08-01 GB GBGB9616237.5A patent/GB9616237D0/en active Pending
-
1997
- 1997-06-03 AU AU30381/97A patent/AU721920B2/en not_active Expired
- 1997-06-03 WO PCT/GB1997/001502 patent/WO1998005302A1/en active IP Right Grant
- 1997-06-03 NZ NZ333986A patent/NZ333986A/xx not_active IP Right Cessation
- 1997-06-03 DE DE69711637.9T patent/DE69711637T3/de not_active Expired - Lifetime
- 1997-06-03 EP EP97925141.0A patent/EP0918507B2/en not_active Expired - Lifetime
- 1997-06-03 JP JP50769598A patent/JP4794701B2/ja not_active Expired - Lifetime
- 1997-06-03 AT AT97925141T patent/ATE215359T2/de active
- 1997-06-03 DK DK97925141.0T patent/DK0918507T4/da active
- 1997-06-03 PT PT97925141T patent/PT918507E/pt unknown
- 1997-06-03 CA CA002261879A patent/CA2261879C/en not_active Expired - Lifetime
- 1997-06-03 ES ES97925141T patent/ES2175413T5/es not_active Expired - Lifetime
- 1997-06-04 US US08/999,752 patent/US7566445B1/en not_active Expired - Fee Related
-
1999
- 1999-01-29 NO NO19990454A patent/NO325491B1/no not_active IP Right Cessation
-
2009
- 2009-05-29 US US12/455,236 patent/US8834849B2/en not_active Expired - Fee Related
-
2011
- 2011-04-25 JP JP2011097582A patent/JP2011173910A/ja active Pending
-
2014
- 2014-07-16 US US14/333,115 patent/US9650203B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090246148A1 (en) | 2009-10-01 |
WO1998005302A1 (en) | 1998-02-12 |
ES2175413T3 (es) | 2002-11-16 |
ES2175413T5 (es) | 2016-05-26 |
DE69711637D1 (de) | 2002-05-08 |
DE69711637T2 (de) | 2002-11-28 |
EP0918507B2 (en) | 2015-12-09 |
PT918507E (pt) | 2002-09-30 |
US20140326759A1 (en) | 2014-11-06 |
JP2000515536A (ja) | 2000-11-21 |
US8834849B2 (en) | 2014-09-16 |
DK0918507T3 (da) | 2002-07-29 |
CA2261879A1 (en) | 1998-02-12 |
NO990454L (no) | 1999-03-29 |
US7566445B1 (en) | 2009-07-28 |
ATE215359T2 (de) | 2002-04-15 |
NO990454D0 (no) | 1999-01-29 |
NO325491B1 (no) | 2008-05-19 |
AU721920B2 (en) | 2000-07-20 |
US9650203B2 (en) | 2017-05-16 |
DE69711637T3 (de) | 2016-04-28 |
AU3038197A (en) | 1998-02-25 |
EP0918507A1 (en) | 1999-06-02 |
EP0918507B1 (en) | 2002-04-03 |
NZ333986A (en) | 1999-05-28 |
CA2261879C (en) | 2006-10-03 |
JP4794701B2 (ja) | 2011-10-19 |
GB9616237D0 (en) | 1996-09-11 |
JP2011173910A (ja) | 2011-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0918507T4 (da) | Aerosolformuleringer | |
EP0499344B1 (en) | Medicinal aerosol formulations | |
ES2294386T3 (es) | Composiciones de aerosol. | |
EP1069887B1 (en) | Aerosol composition | |
KR100696746B1 (ko) | 가압화되고 계량되는 도스흡입기 | |
JP5392880B2 (ja) | 加圧式定量吸入器のための安定な製薬学的溶液製剤 | |
CZ184694A3 (en) | Pharmaceutical preparation | |
EP0775484B1 (en) | Surfactant free aerosol formulations containing beclomethsone dipropionate | |
KR0175164B1 (ko) | 에어로졸 약물 제제 |